Evidence-based preventive treatment of migraine.
Handb Clin Neurol
; 199: 219-241, 2024.
Article
en En
| MEDLINE
| ID: mdl-38307648
ABSTRACT
The evidence base for migraine prevention in both episodic and chronic migraine is outlined. The older oral preventatives, including antidepressants, antihypertensives, serotonin antagonists, antiepileptics, and calcium channel antagonists, and newer options including onabotulinumtoxinA and the CGRP monoclonal antibodies are covered. Many of the older oral preventatives were trialed before chronic migraine was defined, and they are used in chronic migraine based on the assumption that episodic migraine and chronic migraine are on a spectrum of the same condition. First- and second-line options are given, and a multicountry perspective is considered.
Palabras clave
Texto completo:
1
Colección:
01-internacional
Banco de datos:
MEDLINE
Asunto principal:
Trastornos Migrañosos
/
Anticuerpos Monoclonales
Límite:
Humans
Idioma:
En
Revista:
Handb Clin Neurol
Año:
2024
Tipo del documento:
Article
País de afiliación:
Reino Unido